Research theme for competitive and other funds (2):
2021 - 2024 Phf24に着目した新規てんかん病態メカニズムの解明
2021 - 2024 Analysis of the mechanisms underlying development of neuropsychiatric diseases with focus on astrocytic potassium buffering function
Papers (20):
Masaki Kato, Naofumi Kunisawa, Saki Shimizu, Higor A. Iha, Yukihiro Ohno. Mechanisms Underlying Dopaminergic Regulation of Nicotine-Induced Kinetic Tremor. Frontiers in Pharmacology. 2022. 13
Yukihiro Ohno, Naofumi Kunisawa, Saki Shimizu. Emerging Roles of Astrocyte Kir4.1 Channels in the Pathogenesis and Treatment of Brain Diseases. International Journal of Molecular Sciences. 2021. 22. 19. 10236-10236
Kunisawa Naofumi, Hisadumi Hiroaki, Kato Masaki, Shimizu Saki, Sato Kazuaki, Kinboshi Masato, Matsuhashi Masao, Ikeda Akio, Serikawa Tadao, Ohno Yukihiro. Evaluation of seizure sensitivity and potential excitation foci in Phf24-KO rats. Proceedings for Annual Meeting of The Japanese Pharmacological Society. 2021. 94. 3-P1-38
In Vivo Neuropharmacology and Neurophysiology
Springer 2017
Professional career (1):
博士(薬学) (大阪薬科大学)
Association Membership(s) (5):
日本てんかん学会近畿地方会
, THE PHARMACEUTICAL SOCIETY OF JAPAN
, THE JAPAN NEUROSCIENCE SOCIETY
, THE JAPANESE SOCIETY OF NEUROPSYCHOPHARMACOLOGY
, THE JAPANESE PHARMACOLOGICAL SOCIETY